The binding of thionine (3,6-diaminophenothiazine) to trypsin is associated with a red shift in the visible absorption spectrum of the dye. Spectrophotometric titration and equilibrium dialysis measurements are consistent with the presence of a single thionine-binding site on the trypsin molecule. At pH 7 and 4°, Kdiss for the trypsin-thionine complex is 1.2 x 10-5 m. The dye is displaced from trypsin by substrates, competitive inhibitors, and the chemically reactive substrate analogue 1-chloro-3-tosylamido-7-amino-2-heptanone. Thus, the thionine-binding site overlaps with the active site region in trypsin. The dye binds very weakly to trypsinogen, with little spectral perturbation. Thionine, at low concentrations, also binds at a single site on chymotrypsin and chymotrypsinogen, showing the same spectral characteristics and a Kdiss value of 4.5 x 10-4 m at pH 7.0 and 4°. The binding of thionine to chymotrypsin is not affected by substrates, inhibitors, or chemically reactive substrate analogues; hence, the thionine-binding site in chymotrypsin does not appear to include any part of the active site region.
No takes yet. Share an insight, caveat, or question.
Alexander N. Glazer (1967) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: